Visit https://www.peervoice.com/ETU860 to view the entire programme with slides. After completing “Brandon Sheffield, MD, FRCPC - Identifying Actionable Targets in Solid Tumours: The Importance of Comprehensive Genomic Profiling”, participants will be able to: Discuss the role of tumour-agnostic treatments in cancer care and the need for comprehensive genomic profiling (CGP) in patients with solid tumours; Review guideline recommendations for genomic testing in patients with solid tumours; and Formulate best practices for CGP to optimize patient outcomes.